Pfizer (PFE)
NYSE:PFE
Holding PFE?
Track your performance easily

Pfizer (PFE) Income Statement

31,047 Followers

Pfizer Income Statement

Last quarter (Q3 2024), Pfizer's total revenue was $17.70B, an increase of 33.78% from the same quarter last year. In Q3, Pfizer's net income was $4.46B. See Pfizer’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 60.11B$ 58.50B$ 100.33B$ 81.29B$ 41.65B$ 41.17B
Cost of Revenue
$ 19.50B$ 24.95B$ 34.34B$ 30.82B$ 8.48B$ 8.25B
Gross Profit
$ 40.61B$ 33.54B$ 65.99B$ 50.47B$ 33.17B$ 32.92B
Operating Expense
$ 25.73B$ 30.18B$ 31.04B$ 31.03B$ 24.34B$ 25.61B
Operating Income
$ 1.16B$ 316.00M$ 34.94B$ 19.43B$ 8.83B$ 7.32B
Net Non Operating Interest Income Expense
$ -2.06B$ -585.00M$ 1.61B$ 1.44B$ -1.38B$ -1.35B
Other Income Expense
$ -12.17B$ -1.72B$ 217.00M$ -4.88B$ -415.00M$ 5.52B
Pretax Income
$ 3.90B$ 1.06B$ 34.73B$ 24.31B$ 7.04B$ 11.48B
Tax Provision
$ -387.00M$ -1.11B$ 3.33B$ 1.85B$ 370.00M$ 618.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 4.25B$ 2.12B$ 31.37B$ 21.98B$ 9.16B$ 16.27B
Basic EPS
$ 0.75$ 0.38$ 5.59$ 3.92$ 1.73$ 2.92
Diluted EPS
$ -60.28$ 0.37$ 5.47$ 3.85$ 1.71$ 2.87
Basic Average Shares
$ 16.99B$ 5.64B$ 5.61B$ 5.60B$ 5.55B$ 5.57B
Diluted Average Shares
$ 17.15B$ 5.71B$ 5.73B$ 5.71B$ 5.63B$ 5.67B
Dividend Per Share
$ 2.51$ 1.64$ 1.61$ 1.57$ 1.52$ 1.44
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ 2.22$ 1.91
Rent Expense Supplemental
------
Total Expenses
$ 45.23B$ 55.14B$ 65.39B$ 61.85B$ 32.82B$ 33.86B
Net Income From Continuing And Discontinued Operation
$ 4.25B$ 2.12B$ 31.41B$ 21.98B$ 9.16B$ 16.27B
Normalized Income
$ 13.97B$ 8.99B--$ 8.21B$ 6.39B
Interest Expense
----$ 1.45B$ 1.57B
EBIT
$ 8.35B$ 3.27B$ 34.48B$ 24.27B$ 8.48B$ 13.06B
EBITDA
$ 15.24B$ 9.56B$ 39.54B$ 29.47B$ 13.26B$ 18.85B
Currency in USD

Pfizer Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis